Allogene Therapeutics: 2Q Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Allogene Therapeutics Inc. (ALLO) on Wednesday reported a loss of $41.2 million in its second quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 41 cents.
The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.
Allogene Therapeutics shares have climbed 10% since the beginning of the year.